Biogenera
Bologna, IT · Founded 2008 · 22 employees on LinkedIn · 1 known investors
Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.
Founders & leadership
Biogenera was founded in 2008 by Roberto Tonelli.
RT
Roberto TonelliinFounder · President2009–2019
Investors · 1
Frequently asked questions
- What does Biogenera do?
- Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.
- Who founded Biogenera?
- Biogenera was founded by Roberto Tonelli in 2008.
- Who are Biogenera's investors?
- Biogenera's investors include Italian Angels for Growth.
- Where is Biogenera headquartered?
- Biogenera is headquartered in Bologna, IT.
